The Recall Desk
ModerateFDA (Drugs)·D-1137-2022·Announced 2022-06-22

Streptococcinum Homeopathic Drug Recalled Due to Manufacturing Deviations

Washington Homeopathic Products is voluntarily recalling Streptococcinum homeopathic drug in multiple potencies due to manufacturing practice deviations. No illnesses have been reported.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is a FDA Class II voluntary recall with no reported illnesses or injuries. The recall is due to manufacturing process deviations and was initiated by the company, meeting the criteria for a voluntary precautionary recall.

Plain-English summary

Washington Homeopathic Products, Inc. is recalling Streptococcinum homeopathic drug in potencies 8C, 9C, 30C, and 200C supplied in 5 glass amber bottles. Affected lot numbers are 21902 and 21927.

The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. The FDA classified this as a Class II recall on June 10, 2022. The company voluntarily initiated the recall on May 13, 2022.

The product was distributed nationwide throughout the United States. The recall was terminated on May 25, 2023.

The recalled product

Product
Streptococcinum, Potency: 8C, 9C, 30C, 200C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
Manufacturer
Washington Homeopathic Products, Inc.
Category
Drug — Homeopathic
Hazard
  • manufacturing-deviation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot# 21902
  • 21927

Distribution

Distributed nationwide across the United States.

Related recalls

Same category